Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:1042-1049
Published online before print October 13, 2003, doi: 10.1161/01.HYP.0000095614.91961.40
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/5/1042    most recent
01.HYP.0000095614.91961.40v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mozaffari, M. S.
Right arrow Articles by Schaffer, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mozaffari, M. S.
Right arrow Articles by Schaffer, S. W.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Hypertension - basic studies
Right arrow Ischemic biology - basic studies
Right arrow Myocardial cardiomyopathy disease
Right arrow Glucose intolerance

(Hypertension. 2003;42:1042.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Effect of Hypertension and Hypertension-Glucose Intolerance on Myocardial Ischemic Injury

Mahmood S. Mozaffari; Stephen W. Schaffer

From the Department of Oral Biology and Maxillofacial Pathology, Medical College of Georgia School of Dentistry (M.S.M.), Augusta, Ga, and the Department of Pharmacology, College of Medicine, University of South Alabama (S.W.S.), Mobile, Ala.

Correspondence to Dr Mahmood S. Mozaffari, Department of Oral Biology and Maxillofacial Pathology, CB 3710 Medical College of Georgia, Augusta, GA 30912-1128. E-mail Mmozaffa{at}mail.mcg.edu

Systemic hypertension and type 2 diabetes mellitus are major risk factors for myocardial infarction. Yet, glucose intolerance, a prelude stage to type 2 diabetes, is associated with reduced infarct size. Since chronic hypertension adversely affects the myocardium, we tested the hypothesis that the coexistence of systemic hypertension and glucose intolerance reverses the cardioprotection associated with impaired glucose tolerance. Hearts from 9-month-old animals were subjected to a 40-minute occlusion of the left coronary artery followed by 2 hours of reperfusion. Before ischemia, similar values for the four experimental groups were observed for the coronary flow, heart rate, and maximum ventricular pressure. During the course of the ischemia-reperfusion insult, the two hypertensive groups displayed greater reductions in contractility than their normotensive counterparts. Infarct size was lower in the normotensive glucose-intolerant rat than in the normotensive control rat. Surprisingly, the hypertrophied hearts of the hypertensive and hypertensive glucose-intolerant rats displayed reduced infarct size (P<0.05). However, raising the afterload pressure from 100 to 160 cm H2O increased infarct size in the two hypertensive groups. This narrowed the differential between the hypertensive glucose-intolerant (160 cm H2O) and the normotensive control (100 cm H2O) rats. Nonetheless, at the higher afterload pressure, infarct size was less in the hypertensive glucose-intolerant rats than in their hypertensive counterparts. In conclusion, the impairment in contractile function despite the reduction in infarct size underscores the increased susceptibility of the hypertrophied, hypertensive heart to ischemic injury. Furthermore, exacerbation of cell death at elevated afterload pressure indicates the potential benefit of aggressive antihypertensive therapy.


Key Words: hypertension, chronic • glucose • myocardial infarction • myocardial contraction




This article has been cited by other articles:


Home page
HypertensionHome page
M. S. Mozaffari, C. Patel, and S. W. Schaffer
Mechanisms Underlying Afterload-Induced Exacerbation of Myocardial Infarct Size: Role of T-Type Ca2+ Channel
Hypertension, May 1, 2006; 47(5): 912 - 919.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P. Monteiro, L. Goncalves, and L. A Providencia
Diabetes and cardiovascular disease: the road to cardioprotection
Heart, December 1, 2005; 91(12): 1621 - 1625.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Pastukh, S. Wu, C. Ricci, M. Mozaffari, and S. Schaffer
Reversal of hyperglycemic preconditioning by angiotensin II: role of calcium transport
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1965 - H1975.
[Abstract] [Full Text] [PDF]